Lextrading

$PANW Stock prices may swing wildly on sentiment and headlines, but over the long arc they always realign with fundamentals. That’s why I’m comfortable buying dips in wide‑moat companies when the selloff is purely emotional and the underlying business remains as strong as ever.

@adamkhootrader You forgot the sells on Visa and MasterCard. Very disappointing moves from Abel.

Shocking that Berkshire dumped UNH before the recent recovery rally ( possibly at a loss) , dumped Amazon bought back delta airlines ( which they previously cut loss on ) , bought Macy’s( looks like a value trap ) and bought Googl after its had its strongest rally and when its overvalued WTF is going on there ?? Lost their f**kng minds

@SayNoToTrading This will make you feel better. We're getting in at a historically attractive multiple and trough.

Messed up big time with my $SPGI buy. Was trying for $344.44 average cost.

$FIG The bear case for Figma was that AI would compress seats, automate design work, and erode its collaborative moat, but we are seeing the opposite -- AI is expanding Figma’s seat footprint, not shrinking it.

FAST Graphs is outstanding for reviewing fundamentals trends. Their visual format helps you quickly spot undervalued or overvalued stocks. I’ve partnered with FAST Graphs to extend a 25% discount on subscriptions. discount code: AFFILIATE25. fastgraphs.com/?ref=kevinqi

$PAYX has a wide, durable moat, driven by regulatory entrenchment, workflow lock‑in, switching costs, and scale. According to FAST Graphs, the stock is trading at multiples that were last seen during the 2008 GFC and 2020 covid-19 pandemic. Dividend yield at 5.25%.

$SMH How much higher can semis go? It's now above its major resistance trendline. Risk/reward looks poor.

From a technical standpoint, the stock is also approaching a major resistance trendline.

$ASML On a 10-year basis, ASML’s P/E is above its historical average, approaching its peak level in the 50s. This suggests the risk/reward profile today is poor.

$PANW They hated it at the lows but can't stop chasing it now.

@SayNoToTrading You definitely can, but you won't 😄. I can get you a 25% discount off the subscription. Use my discount code AFFILIATE25 and the link below. fastgraphs.com/?ref=kevinqi

@LXVOptions Thanks, I can't afford Fastgraphs. Yeah I have $SYK ranging from around $320 down to 280s. Plan to keep the 200 in the 280s.

So many software stocks to buy today, so what should we cross off list? When it comes to big legacy, $ORCL over $SAP all day, even after this run. I did buy SAP in 2022 and sold way too early, I think it was in $120s. Don't regret it though because look at long term chart, does this look like a long term buy and hold to you? Even with dividends reinvested, returns are rubbish vs. S&P. Plus, don't forget the German dividend withholding tax of 26.375%. I did buy 100 of $PLTR but the other much bigger buys of a dozen+ are non X stocks, so no one cares about them.

@SayNoToTrading Not SaaS but right up your alley. Stryker (SYK).

@LXVOptions Bought some too.

$CAT Poor risk/reward

@realroseceline Thinking about $MELI

One thing investors miss in the short term is separating deterioration in business quality from temporary investment cycle pressure. Margin compression gets treated as if the moat suddenly disappeared overnight, when in reality what is happening is that a dominant platform is deliberately reinvesting to strengthen the ecosystem and expand market share. 🌹

The current combination of a technical floor, valuation compression, and a temporary external shock make Stryker a compelling opportunity. open.substack.com/pub/lextrading…

Technical Support: SYK has plummeted to a major support/resistance pivot at $281. This level aligns with a massive “volume shelf” (high-volume node), indicating significant institutional interest and price defense at this zone.

$SYK Stryker is a global titan in medical technology, dominating the “hospital backbone” through its MedSurg, Orthopaedics, and Neurotechnology divisions. Despite these structural strengths, SYK is currently trading ~30% below its July 2025 all-time highs. 🧵:

This is limited to the first 200 people and the offer expires on May 31st. It will go fast! You must use this special link to access the private offer (and add the discount code) stockanalysis.com/pro/trial/?ref…

Stock Analysis Unlimited (Annual) • 1 month free • Then just $8.29 per month for the first year (50% off) • Code: LEX50

$PANW Stock prices may swing wildly on sentiment and headlines, but over the long arc they always realign with fundamentals. That’s why I’m comfortable buying dips in wide‑moat companies when the selloff is purely emotional and the underlying business remains as strong as ever.